Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALEX N GONZALEZ BOSSOLO

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1457606444
CMS profile
2782156
Location
SAN JUAN, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$19,020.13

152 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALEX N GONZALEZ BOSSOLO

NPI 1457606444 · CMS profile ID 2782156

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

SAN JUAN, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1457606444?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALEX N GONZALEZ BOSSOLO, NPI 1457606444, CMS profile ID 2782156. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1457606444?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ALEX N GONZALEZ BOSSOLO, NPI 1457606444, CMS profile ID 2782156. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1457606444?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ALEX N GONZALEZ BOSSOLO, NPI 1457606444, CMS profile ID 2782156, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 152 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1457606444?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

152 matching records · $19,020.13 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 152 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 152.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $25.0004/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086843021 CMS
Corcept Therapeutics $25.0004/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117791554 CMS
Abbott Laboratories $20.6304/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125075800 CMS
Abbott Laboratories $8.3004/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125075802 CMS
Novo Nordisk Inc $11.6504/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096562041 CMS
Bayer Puerto Rico Inc. $25.0004/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086133364 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $9.3504/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118017377 CMS
Bayer Healthcare Pharmaceuticals Inc. $124.5004/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086253420 CMS
AstraZeneca Pharmaceuticals LP $40.0303/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104778204 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $107.9503/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118017393 CMS
Dexcom, Inc. $20.0703/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153277314 CMS
Novo Nordisk Inc $18.4603/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096563207 CMS
ABBVIE INC. $21.4403/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103817948 CMS
Abbott Laboratories $22.3003/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125075794 CMS
Abbott Laboratories $7.1803/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125075796 CMS
Abbott Laboratories $7.8603/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125075798 CMS
Boston Scientific Corporation $47.1103/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092236068 CMS
Bayer Puerto Rico Inc. $22.7303/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086201728 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $11.2003/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118017379 CMS
Novartis Pharmaceuticals Corporation $74.2403/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086843007 CMS
Novo Nordisk Inc $20.0002/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096560585 CMS
Corcept Therapeutics $25.0002/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117791546 CMS
AstraZeneca Pharmaceuticals LP $22.8302/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104349394 CMS
Abbott Laboratories $7.4502/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125075792 CMS
Lilly USA, LLC $3,600.0002/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136018257 CMS
Bayer Puerto Rico Inc. $25.0002/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086218575 CMS
Eli Lilly Export S.A. Puerto Rico Branch $32.8202/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136020988 CMS
Lilly USA, LLC $754.0002/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135996296 CMS
Lilly USA, LLC $60.0002/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135996298 CMS
Lilly USA, LLC $209.0002/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136012841 CMS
Lilly USA, LLC $2.7902/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136016091 CMS
Lilly USA, LLC $25.0002/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136016093 CMS
Lilly USA, LLC $2.4502/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136017237 CMS
Lilly USA, LLC $6.8002/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136017239 CMS
Lilly USA, LLC $224.0002/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136017243 CMS
Lilly USA, LLC $35.0002/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136017245 CMS
Lilly USA, LLC $25.0002/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136018253 CMS
Lilly USA, LLC $55.0002/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136018255 CMS
Lilly USA, LLC $32.0002/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136018499 CMS
Lilly USA, LLC $113.0002/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136018501 CMS
Lilly USA, LLC $1.8402/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136018503 CMS
Lilly USA, LLC $31.8702/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136019572 CMS
Bayer Puerto Rico Inc. $17.2702/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086245768 CMS
Novo Nordisk Inc $18.7502/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096560625 CMS
Bayer Puerto Rico Inc. $20.0001/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086172798 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.1601/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118017387 CMS
Novo Nordisk Inc $20.0001/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096561585 CMS
SANOFI-AVENTIS U.S. LLC $130.6301/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139877961 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.0801/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118017389 CMS
AstraZeneca Pharmaceuticals LP $24.8401/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105769100 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,043.19 121
PY2020 $2,485.15 76
PY2021 $2,677.52 100
PY2022 $22,441.64 136
PY2023 $22,080.65 133
PY2024 $19,020.13 152
PY2025 $38,262.94 148

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $2,415,559.21 11
PY2024 Recipient $11,114.00 2
PY2024 Principal investigator $878,140.83 12
PY2023 Recipient $1,241.73 3
PY2023 Principal investigator $823,858.07 27
PY2022 Recipient $12,995.00 3
PY2022 Principal investigator $253,203.92 10
PY2021 Recipient $14,963.20 3
PY2021 Principal investigator $632,879.01 8
PY2020 Recipient $24,667.97 2
PY2020 Principal investigator $392,925.74 2
PY2019 Recipient $11,275.92 2
PY2019 Principal investigator $770.40 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $30,331.12 10/10/2025 Non-covered Recipient Entity
LATIN CLINICAL TRIAL CENTER
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Atherosclerotic Cardiovascular Disease (ASCVD), and Elevated LDL-C No dispute reported 06/30/2026 1190300021
Principal investigator 1 Amgen Inc. $214,381.00 08/01/2025 Non-covered Recipient Entity
INTERSPOND LLC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-2) No dispute reported 06/30/2026 1246642878
Principal investigator 1 Amgen Inc. $595,641.05 04/24/2025 Non-covered Recipient Entity
INTERSPOND LLC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight No dispute reported 06/30/2026 1246642906
Principal investigator 1 Novartis Pharmaceuticals Corporation $58,099.79 02/27/2025 Non-covered Recipient Entity
LATIN CLINICAL TRIAL CENTER
A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established atherosclerotic cardi No dispute reported 06/30/2026 1190300019
Principal investigator 1 Amgen Inc. $42,615.09 02/25/2025 Non-covered Recipient Entity
LATIN CLINICAL TRIAL CENTER
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-2) No dispute reported 06/30/2026 1246643500
Principal investigator 1 Amgen Inc. $93,484.55 02/25/2025 Non-covered Recipient Entity
LATIN CLINICAL TRIAL CENTER
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight No dispute reported 06/30/2026 1246643507
Principal investigator 1 Eli Lilly and Company $1,201.20 01/31/2025 Non-covered Recipient Entity
LATIN CLINICAL TRIAL CENTER INC
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LY3437943 ONCE WEEKLY COMPARED TO PLACEBO IN PARTICIPANTS WITH SEVERE OBESITY AND ESTABLISHED CARDIOVASCULAR DISEASE No dispute reported 06/30/2026 1187884566
Principal investigator 1 Eli Lilly and Company $2,470.00 01/27/2025 Non-covered Recipient Entity
LATIN CLINICAL TRIAL CENTER INC
A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1187885968
Principal investigator 1 Eli Lilly Export S.A. Puerto Rico Branch $299,585.00 01/21/2025 Non-covered Recipient Entity
LATIN CLINICAL TRIAL CENTER INC
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LY3437943 ONCE WEEKLY COMPARED TO PLACEBO IN PARTICIPANTS WITH SEVERE OBESITY AND ESTABLISHED CARDIOVASCULAR DISEASE No dispute reported 06/30/2026 1187884354
Principal investigator 1 Eli Lilly Export S.A. Puerto Rico Branch $57,232.00 01/21/2025 Non-covered Recipient Entity
LATIN CLINICAL TRIAL CENTER INC
A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1187885362
Principal investigator 1 Amgen Inc. $1,020,518.41 01/03/2025 Non-covered Recipient Entity
LATIN CLINICAL TRIAL CENTER
A Study to Evaluate the Efficacy, Safety & Tolerability of Maridebart Cafraglutide in Adults With T2DM No dispute reported 06/30/2026 1246643511